Syngenta announced today that it will be accelerating the development of innovative technology that will dramatically increase the sugar content of cane.
The technology will be based on Syngenta's own biotech research in combination with SugarBooster™ a technology that uses genetic modification to introduce an enzyme into a plant to help increase sugar content. Syngenta has signed an exclusive license agreement for SugarBooster™ with CSR Sugar, a sugar and renewable energy company from Australia.
"The combination of SugarBooster™ with our own sugar cane biotechnology will help accelerate our effort to maximize the yield of sugar per hectare of sugar cane. The development of sugar boosting technology will bring our customers productivity gains and economic benefits in meeting the increased demand for sugar and ethanol," said Marco Bochi, Head of New Technologies in cane for Syngenta in Latin America.
Syngenta has acquired exclusive global rights, Australia excluded, to SugarBooster™ for key sugar crops. The license agreement includes milestone payments and royalties on product sales to CSR Sugar. Additional terms of the deal were not disclosed.
Syngenta has more than 40 on-going projects at various stages aimed at improving agronomic performance, insect control, weed control and sugar elevation. In 2008, the company announced the development of Plene™. Through the planting of four centimeter buds treated with Syngenta products, this technology will bring significant reduction in planting costs per hectare, in addition to environmental benefits due to reduced soil compacting.
According to FAO, by 2050 the world population will grow to nine billion people and global food production will have to increase by 50%. Syngenta invests in innovative technologies to grow more from less land in order to respond to the global challenge of increasing demand for food, feed and energy.
Syngenta Media:
Nêmora Reche Brazil +11 5643-3991
Monica Salles Brazil +11 5643-6767
Syngenta Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.
